UCB - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Alcon AG USD 189M 28M 2026-03
Almirall EUR 19.58M 7M 2025-12
Amarin USD -1.22M 6.51M 2025-12
argenx SE USD 366M 166.95M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Genmab DKK 31M 370M 2025-12
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GRIFOLS EUR 73M 25.25M 2026-03
Hikma Pharmaceutical USD 164M 45M 2025-12
Lakefront Biotherapeutics EUR 14.49M 767.65M 2026-03
Lonza CHF 426M 119M 2025-06
Merck EUR 659M 340M 2026-03
Novartis USD 3.16B 747M 2026-03
Orion EUR 90.4M 170.1M 2026-03
Recordati EUR 153.06M 35.75M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
UCB EUR 1.08B 608M 2025-12
Unibail Rodamco EUR 532.1M 123.6M 2025-12